Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
This report contains market size and forecasts of Japanese Encephalitis Vaccines in global, including the following market information:
Global Japanese Encephalitis Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Japanese Encephalitis Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Japanese Encephalitis Vaccines companies in 2021 (%)
The global Japanese Encephalitis Vaccines market was valued at 214.6 million in 2021 and is projected to reach US$ 302.4 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Attenuated Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Japanese Encephalitis Vaccines include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group and Valneva Products, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Japanese Encephalitis Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Japanese Encephalitis Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Japanese Encephalitis Vaccines Market Segment Percentages, by Type, 2021 (%)
Attenuated Vaccines
Inactivated Vaccines
Global Japanese Encephalitis Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Japanese Encephalitis Vaccines Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Global Japanese Encephalitis Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Japanese Encephalitis Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Japanese Encephalitis Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Japanese Encephalitis Vaccines revenues share in global market, 2021 (%)
Key companies Japanese Encephalitis Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Japanese Encephalitis Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products